LIVE fireside chat: OncXerna’s novel approach to precision drug development

LIVE fireside chat: OncXerna’s novel approach to precision drug development

Tuesday, March 30, 2021 4:00 PM to 4:20 PM · 20 min. (Africa/Abidjan)

Immunotherapy

Tumor microenvironment

Fireside chat

Information

· Understanding cancer biology from the ground up
· Intersecting RNA-seq & AI to build new diagnostics
· Addressing bias & abstracting complexity in clinical datasets
· Matching biology to the antibody therapeutics bavituximab and navicixizumab

Laura Benjamin, Founder and CEO, OncXerna & Rafael Rosengarten, CEO, Genialis

GenialisGenialis is a data science and drug discovery company focused on new ways to treat disease. Blending computational biology and AI-based methods, Genialis merges and models data at the intersection of clinical and translational medicine. Genialis is trusted by biopharma and big pharma alike, to identify targets, predict biomarkers and optimally position novel drugs. Together, Genialis and its partners work to bring improved solutions to drug discovery to change people's lives.

Log in

See all the content and easy-to-use features by logging in